66 related articles for article (PubMed ID: 21034825)
1. A single immunization near birth elicits immediate and lifelong protective immunity.
Reikie BA; Smolen KK; Fortuno ES; Loeffler DI; Cai B; Blimkie D; Kollmann TR
Vaccine; 2010 Dec; 29(1):83-90. PubMed ID: 21034825
[TBL] [Abstract][Full Text] [Related]
2. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine.
Lauvau G; Vijh S; Kong P; Horng T; Kerksiek K; Serbina N; Tuma RA; Pamer EG
Science; 2001 Nov; 294(5547):1735-9. PubMed ID: 11721060
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
6. Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells.
Huster KM; Koffler M; Stemberger C; Schiemann M; Wagner H; Busch DH
Eur J Immunol; 2006 Jun; 36(6):1453-64. PubMed ID: 16637009
[TBL] [Abstract][Full Text] [Related]
7. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
8. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: memory CD8 T cell compartment grows in size with immunological experience but nevertheless can lose function.
Huster KM; Stemberger C; Gasteiger G; Kastenmüller W; Drexler I; Busch DH
J Immunol; 2009 Dec; 183(11):6898-902. PubMed ID: 19890045
[TBL] [Abstract][Full Text] [Related]
10. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes.
White DW; MacNeil A; Busch DH; Pilip IM; Pamer EG; Harty JT
J Immunol; 1999 Jan; 162(2):980-8. PubMed ID: 9916723
[TBL] [Abstract][Full Text] [Related]
11. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12.
Miller MA; Skeen MJ; Ziegler HK
Cell Immunol; 1998 Mar; 184(2):92-104. PubMed ID: 9630835
[TBL] [Abstract][Full Text] [Related]
12. Neonatal immunization with Listeria monocytogenes induces T cells with an adult-like avidity, sensitivity, and TCR-Vbeta repertoire, and does not adversely impact the response to boosting.
Smolen KK; Loeffler DI; Reikie BA; Aplin L; Cai B; Fortuno ES; Kollmann TR
Vaccine; 2009 Dec; 28(1):235-42. PubMed ID: 19796722
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
14. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
[TBL] [Abstract][Full Text] [Related]
15. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.
Brockstedt DG; Bahjat KS; Giedlin MA; Liu W; Leong M; Luckett W; Gao Y; Schnupf P; Kapadia D; Castro G; Lim JY; Sampson-Johannes A; Herskovits AA; Stassinopoulos A; Bouwer HG; Hearst JE; Portnoy DA; Cook DN; Dubensky TW
Nat Med; 2005 Aug; 11(8):853-60. PubMed ID: 16041382
[TBL] [Abstract][Full Text] [Related]
16. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
17. The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms.
Weiskirch LM; Pan ZK; Paterson Y
Clin Immunol; 2001 Mar; 98(3):346-57. PubMed ID: 11237558
[TBL] [Abstract][Full Text] [Related]
18. The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes.
Bioley G; Zehn D; Lassus A; Terrettaz J; Tranquart F; Corthésy B
Biomaterials; 2013 Jul; 34(21):5423-30. PubMed ID: 23618628
[TBL] [Abstract][Full Text] [Related]
19. The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma.
Paglia P; Arioli I; Frahm N; Chakraborty T; Colombo MP; Guzmàn CA
Eur J Immunol; 1997 Jun; 27(6):1570-5. PubMed ID: 9209512
[TBL] [Abstract][Full Text] [Related]
20. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
